Chromocell Issues Letter to Stockholders from Chief Executive Officer
FREEHOLD, N.J., April 09, 2024 (GLOBE NEWSWIRE) — Chromocell Therapeutics Corporation (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer […]
Verizon powers digital government for the Commonwealth of Virginia
RICHMOND, Va., April 09, 2024 (GLOBE NEWSWIRE) — Verizon, a leading provider of communication and technology solutions, has successfully implemented […]
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
BASKING RIDGE, N.J., April 09, 2024 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage […]
Leading German Auto Finance Company Goes Live with Full NFS Ascent Suite to Support Operations in South Korea
ENCINO, Calif., April 09, 2024 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), the global leader in delivering state-of-the-art solutions […]
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
HORSHAM, Pa., April 09, 2024 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical […]
Stellantis Annual General Meeting Live Webcast Available
Stellantis Annual General Meeting Live Webcast Available AMSTERDAM, April 9, 2024 – Stellantis N.V. announced today that a link for […]
Microchip Brings Enhanced Code Protection and up to 15W of Power Delivery to its USB Microcontroller Portfolio
CHANDLER, Ariz., April 09, 2024 (GLOBE NEWSWIRE) — The well-known advantages of a Universal Serial Bus (USB) interface for embedded designs […]
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism
AUSTIN, Texas, April 09, 2024 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company […]
Clearmind Medicine CEO Issues Letter to Shareholders
Vancouver, Canada, April 09, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq:CMND), (FSE: CWY0) (“Clearmind” or the “company”), a clinical-stage […]
Kartoon Studios Reports Strong Progress and Provides Business Update for the Fourth Quarter and Full Year of 2023
Projected Growth and Cost Saving Initiatives Driving Company Towards Profitability as Animated Characters, Catalogue of Animated Episodes, and Broadcast Assets, […]
